Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis

Experimental Parasitology

Volumn 137, Issue 1, 2014, Pages 53-65

  Sachdeva, Heena ^a   Sehgal, Rakesh ^b   Kaur, Sukhbir ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antileishmanial; Cisplatin; Hepatoprotective; Immunomodulatory; Nephroprotective; Tinospora cordifolia; Visceral leishmaniasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHLORIDE; CISPLATIN; CREATININE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOCYTE SURFACE MARKER; MAGNESIUM; POTASSIUM; PROTEIN NK1.1; SODIUM; TINOSPORA CORDIFOLIA EXTRACT; UNCLASSIFIED DRUG; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; B LYMPHOCYTE; CELL POLARITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RESPONSE; DELAYED HYPERSENSITIVITY; DRUG MEGADOSE; ELECTROLYTE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOMODULATION; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; LIVER PROTECTION; LIVER TOXICITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER T CELL; NEPHROTOXICITY; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; RENAL PROTECTION; SPLEEN INJURY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TINOSPORA CORDIFOLIA; TREATMENT DURATION; UREA BLOOD LEVEL; VISCERAL LEISHMANIASIS;

ANTILEISHMANIAL; CISPLATIN; HEPATOPROTECTIVE; IMMUNOMODULATORY; NEPHROPROTECTIVE; TINOSPORA CORDIFOLIA; VISCERAL LEISHMANIASIS;

ANIMALS; CISPLATIN; CYTOKINES; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; KIDNEY; KIDNEY FUNCTION TESTS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; LIVER FUNCTION TESTS; MALE; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT EXTRACTS; SPLEEN; TINOSPORA;

EID: 84892494583     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2013.12.006     Document Type: Article

References (85)

1. Abdelmeguid N.E., Chmaisse H.N., Abou Zeinab N.S. Silymarin ameliorates cisplatin-induced hepatotoxicity in rats: histopathological and ultrastructural studies. Pak. J. Biol. Sci. 2010, 15(13(10)):463-479.
2. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
3. Afrin F., Ali N. Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. Infect. Immun. 2010, 65(6):2371-2377.
4. Aher V.D., Wahi A. Pharmacological study of Tinospora cordifolia as an immunomodulator. Int. J. Curr. Pharm. Res. 2010, 2(4):52-54.
5. Ait-Oudhia K., Gazanion E., Vergnes B., Oury B., Sereno D. Leishmania antimony resistance: what we know what we can learn from the field. Parasitol. Res. 2011, 109(5):1225-1232.
6. Ajith T.A., Nivitha V., Usha S. Zingiber officinale Roscoe alone and in combination with alpha-tocopherol protect the kidney against cisplatin-induced acute renal failure. Food Chem. Toxicol. 2007, 45(6):921-927.
7. Ali B.H., Al Moundhri M.S. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem. Toxicol. 2006, 44:1173-1183.
8. Ali B.H., Al-Moundhri M.S., Tageldin M., Al-Husseini I.S., Mansour M.A., Nemmar A. Ontogenic aspects of cisplatin-induced nephrotoxicity in rats. Food Chem. Toxicol. 2006, 46:3355-3359.
9. Atessahin A., Yilmaz S., Karahan I., Caribasi A.O., Karaoglu A. Effects of lycopene against cisplatin induced nephrotoxicity and oxidative stress in rats. Toxicology 2005, 212:116-123.
10. Badary O.A., Abdel-Maksoud S., Ahmed W.A., Owieda G.H. Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci. 2005, 76:2125-2135.
11. Bhawya D., Anilkumar K.R. In vitro antioxidant potency of Tinospora cordifolia (gulancha) in sequential extracts. Int. J. Pharm. Biol. Arch. 2010, 1(5):448-456.
12. Bhupindu S., Sharma M.L., Gupta O.P., Atal C.K. Antihepatotoxic activity of Tinospora cordifolia Miers. Indian J. Pharmacol. 1981, 1:96.
13. Bishayi B., Roychowdhury S., Ghosh S., Sengupta M. Hepatoprotective and immunomodulatory properties of Tinospora cordofolia in CCl4 intoxicated mature albino rats. J. Toxicol. 2002, 27(3):139-146.
14. Bradley D.J., Kirkley J. Regulation of Leishmania populations within host. I. the variable course of Leishmania donovani infections in mice. Clin. Exp. Immunol. 1977, 30(1):119-129.
15. Bretscher P.A., Wei G., Menon J.N., Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992, 257:539-542.
16. Chirino Y.I., Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp. Toxicol. Pathol. 2009, 61(3):223-242.
17. Dahanukar S.A., Thatte U.M., Rege N.N. Immunostimulants in ayurveda medicine. Immunomodulatory Agents from Plants 1999, 289-323. Birkhäuser Verlag, Basel, Switzerland. H. Wagner (Ed.).
18. Das A., Ali N. Vaccine development against Leishmania donovani. Front. Immunol. 2012, 3:99.
19. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 2004, 27:305-318.
20. Devprakash Srinivasan K.K., Suhburaju T., Garav S., Singh S. Tinospora cordifolia - a review on its ethnobotany, phytochemical and pharmacological profile. Asian. J. Biochem. Pharm. Res. 2011, 4(1):291-302.
21. Dikshit V., Damre A.S., Kulkarni K.R., Gokhale A., Saraf M.N. Preliminary screening of imunocin for immunomodulatory activity. Indian J. Pharm. Sci. 2000, 62(4):257.
22. Dillioglugil M.O., Kir H.M., Gulkac M.D., Kanil A.O., Ozdogan H.A., Acar O., Dillioglugil O. Protective effects of increasing Vitamin E and A dose on cisplatin-induced oxidative damage to kidney tissue in rats. Urol. Int. 2005, 75:340-344.
23. Donaghy L., Cabillic F., Corlu A., Rostan O., Toutirais O., Guguen-Guillouzo C., Guiguen C., Gangneux J.P. Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment. PLOS Negl. Trop. Dis. 2010, 4:e703.
24. Ghalib H., Whittle J., Kubin M., Hashim F., Grabstein K., Trinchieri G., Reed S. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J. Immunol. 1995, 154:4623-4629.
25. Gangneux J.P., Donaghy L., Marty P. Liver involvement during visceral leishmaniasis. Gastroenterol. Clin. Biol. 2006, 30:1027-1032.
26. Ghalib H.W., Whittle J.A., Kubin M., Hashim F.A., El-Hassan A.M., Grabstein K.H., Trinchieri G., Reed S.G. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J. Immunol. 1995, 154:4623-4629.
27. Handman E. Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 2001, 14(2):229-243.
28. Hanigen M.H., Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003, 1:47-61.
29. Jariyawat S., Kigpituck P., Suksen K., Chuncharunee A., Chaovanalikit A., Piyachaturawat P. Protection against cisplatin-induced nephrotoxicity in mice by Curcuma comosa Roxb. ethanol extract. J. Nat. Med. 2009, 63(4):430-436.
30. Kapil A., Sharma S. Immunopotentiating compounds from Tinospora cordifolia. J. Ethnopharmacol. 1997, 58:89-95.
31. Kaur J., Kaur T., Kaur S. Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB/c mice. Acta Trop. 2011, 119(1):50-56.
32. Kaur S., Sachdeva H., Dhuria S., Sharma M., Kaur T. Antileishmanial effect of cisplatin against murine visceral leishmaniasis. Parasitol. Int. 2010, 59:62-69.
33. Kaur T., Sobti R.S., Kaur S. Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB/c mice. Parasite Immunol. 2011, 33:95-103.
34. Kawai Y., Nakao T., Kunimura N., Kohda Y., Gemba M. Relationship of intracellular calcium and oxygen radicals to cisplatin related renal cell injury. J. Pharmacol. Sci. 2006, 100(1):65-72.
35. Kaye P., Scott P. Leishmaniasis: complexity at the host pathogen interface. Nat. Rev. Microbiol. 2011, 9(8):604-615.
36. Ketterer B. Protective role of glutathione and glutathione S-transferases in mutagenesis and carcinogenesis. Mutat. Res. 1988, 202:343-361.
37. Khanam S., Mohan N.P., Devi K., Sultana R. Protective role of Tinospora cordifolia against cisplatin induced nephrotoxicity. Int. J. Pharm. Pharm. Sci. 2011, 3(4):268-270.
38. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 2003, 8:223-246.
39. Koppada R., Norozian F.M., Torbati D., Kalomiris S., Ramachandran C., Balagangadhar R. Physiological effects of a novel immune stimulator drug, (1,4)-α-d-glucan, in rats. Basic Clin. Pharmacol. Toxicol. 2009, 105(4):217-221.
40. Kumar A., Shrivastav S. A study of antipyretic effect of Guduchi. Sachitra Ayurved 1995, 48:289-291.
41. Lee C.K., Park K.K., Hwang J.K., Lee S.K., Chung W.Y. The pericarp extract of Prunus persica attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in mice. J. Med. Food 2008, 11(2):302-306.
42. Lieber C.S. Cytochrome P450 2E1: its physiological and pathological role. Physiol. Rev. 1997, 77:517-544.
43. Manjrekar P.N., Jolly C.I., Narayanan S. Comparative studies of the immunomodulatory activity of Tinospora cordifolia and Tinospora sinensis. Fitoterapia 2000, 71:254-257.
44. Merritt R.E., Mahtabifard A., Yamada R.E., Crystal R.G., Korst R.J. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer. J. Thorac. Cardiovasc. Surg. 2003, 126:1609-1617.
45. Mu H.H., Sewell W.A. Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin. Immunology 1994, 83:639-645.
46. Murray H.W. Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation. Infect. Immun. 2000, 68:6294-6299.
47. Nagarkatti D.S., Rege N.N., Desai N.K., Dahanukar S.A. Modulation of Kupffer cell activity by Tinospora cordifolia in liver damage. J. Postgrad. Med. 1994, 40:65-67.
48. Nagill R., Kaur S. Vaccine candidates for leishmaniasis: a review. Int. Immunopharmacol. 2011, 11(10):1464-1488.
49. Nair P.K., Melnick S.J., Ramachandran R., Escalon E., Ramachandran C. Mechanism of macrophage activation by (1,4)-alpha-d-glucan isolated from Tinospora cordifolia. Int. Immunopharmacol. 2006, 6(12):1815-1824.
50. Nayampalli S.S., Desai N.K., Ainapure S.S. Antiallergic properties of Tinospora cardifolia in animal models. Indian J. Pharm. 1986, 18:250.
51. Park A.Y., Hondowicz B.D., Scott P. IL-12 is required to maintain a Th-1 response during Leishmania major infection. J. Immunol. 2000, 165:896-902.
52. Perez-Victoria F.J., Castanys S., Gamarro F. Leishmaniasis resistance to translocation of the drug. Antimicrob. Agents Chemother. 2003, 47:2397-2403.
53. Purandare H., Supe A. Immunomodulatory role of Tinospora cordifolia as an adjuvant in surgical treatment of diabetic foot ulcers: a prospective randomized controlled study. Indian J. Med. Sci. 2007, 61(6):347-355.
54. Rao S.K., Rao S.P., Rao N.B. Preliminary investigation of the radio sensitizing activity of Guduchi (Tinospora cordifolia) in tumor bearing mice. Photother. Res. 2008, 22:1482-1489.
55. Rathi S.S., Grover J.K., Vikrant V. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytother. Res. 2002, 16:774-777.
56. Rawal A.K., Muddeshwar M.G., Biswas S.K. Rubia cordifolia, Fagonia cretica linn and Tinospora cordifolia exert neuroprotection by modulating the antioxidant system in rat hippocampal slices subjected to oxygen glucose deprivation. BMC Complement. Altern. Med. 2004, 4:11.
57. Rege N.N., Dahanukar S.A., Karandikar S.M. Hepatoprotective effects of Tinospora cordifolia against carbon tetrachloride induced liver damage. Indian Drugs 1984, 21:544-555.
58. Rege N.N., Nazareth H.M., Bapat R.D., Dahanukar S.A. Modulation of immunosuppression in obstructive jaundice by Tinospora cordifolia. Indian J. Med. Res. 1989, 90:478-483.
59. Sato S., Hori Y., Yamate J., Saito T., Kurasaki M., Hatai A. Protective effect of dietary azuki bean (Vigna angularis) seed coats against renal interstitial fibrosis of rats induced by cisplatin. Nutrition 2005, 21:504-511.
60. Shakya N., Sane S.A., Vishwakarma P., Bajpai P., Gupta S. Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv. Acta Trop. 2011, 119(2-3):188-193.
61. 1 induced toxicity in swiss albino mice. J. Nat. Pharm. 2011, 2(3):125-132.
62. Sharma V., Pandey D. Protective role of Tinospora cordifolia against lead-induced hepatotoxicity. Toxicol. Int. 2010, 17(1):12-17.
63. Singh N., Kumar M., Singh R.K. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac. J. Trop. Med. 2012, 5(6):486-497.
64. Singh N., Singh S.M., Shrivastava P. Immunomodulatory and antitumor actions of medicinal plant Tinospora cordifolia are mediated through activation of tumor-associated macrophages. Immunopharmacol. Immunotoxicol. 2004, 26:145-162.
65. Singh R.K. Tinospora cordifolia as an adjuvant drug in the treatment of hyper-reactive malarious splenomegaly - case reports. J. Vector Borne Dis. 2005, 42:36-38.
66. Singh S.S., Pandey S.C., Srivastava S., Gupta V.S., Patro B., Ghosh A.C. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi). Indian J. Pharmacol. 2003, 35:83-91.
67. Sinha K., Mishra N.P., Singh J., Khanuja S.P.S. Tinospora cordifolia a reservoir plant for therapeutic applications: a review. Indian J. Tradit. Knowledge 2004, 3(3):257-270.
68. Srinevasan G.V., Unnikrishnan K.P., Rema Shree A.B. Balachandran I. HPLC estimation of berberine in Tinospora cordifolia and Tinospora sinensis. Indian. J. Pharm. Sci. 2008, 70(1):96-99.
69. Stanley P., Prince M., Menon V.P. Hypoglycaemic and other related actions of Tinospora cordifolia roots in alloxan-induced diabetic rats. J. Ethnopharmacol. 2000, 70:9-15.
70. Sultana S., Verma K., Khan R. Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress. J. Pharm. Pharmacol. 2012, 64(6):872-881.
71. Sundar S., Chatterjee M. Visceral leishmaniasis-current therapeutic modalities. Indian J. Med. Res. 2006, 123:345-352.
72. Sundar S., More D.K., Singh M.K., Singh V.P., Sharma S., Makharia A., Kumar P.C., Murray H.W. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin. Infect. Dis. 2000, 31:1104-1107.
73. Suvas S., Singh V., Sahdev S., Vohra H., Agrewala J.N. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J. Biol. Chem. 2002, 277:7766-7775.
74. Tavaers J., Quaissi M., Quaissi A., Cordeiro-da-Silva A. Characterization of anti-Leishmania effect induced by cisplatin, an anticancer drug. Acta Trop. 2007, 103:133-141.
75. Thakur C.P., Sinha G.P., Pandey A.K., Kumar N., Kumar P., Hassan S.M., Narain S., Roy R.K. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India; justify its continued use as a first line drug? An observational study of 80 cases. Ann. Trop. Med. Parasitol. 1998, 92(5):561-569.
76. Thatte U.M., Dahanukar S.A. Immunotherapeutic modification of experimental infections by Indian medicinal plants. Phytother. Res. 1989, 3:43-49.
77. Tikoo K., Bhatt D.K., Gaikawad A.B., Sharma V., Kabra D.G. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats. Toxicology 2007, 581(10):2027-2035.
78. Tiwari P., kumar B., Kaur M., Kaur G., Kaur H. Phytochemical screening and extraction: A review. Int. Pharm. Sciencia 2011, 1(1):98-106.
79. Upadhyay A.K., Kumar K., Kumar A., Mishra H.S. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi)-validation of the Ayurvedic pharmacology through experimental and clinical studies. Int. J. Ayurved Res. 2010, 1(2):112-121.
80. Van Basten J.P., Schrafford-Koops H., Sleijfer D.T., Pras E., van Driel M.F., Hoekstra H.J. Current concept about testicular cancer. Eur. J. Surg. Oncol. 1997, 23:354-360.
81. Vennerstrom J.L., Lovelace J.K., Waits V.B., Hanson W.L., Klayman D.L. Berberine derivatives as antileishmanial drugs. Antimicrob. Agents Chemother. 1990, 34:918-921.
82. Wadood N., Wadood A., Shah S.A. Effect of Tinospora cordifolia on blood glu-cose and total lipid levels of normal and alloxan-diabetic rabbits. Planta Med. 1992, 58:31-136.
83. World Health Organization (2010). Control of the Leishmaniasis. WHO (Technical Report Series 949), Geneva, 5-12.
84. Zhang J.G., Lindup W.E. Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem. Pharmacol. 1993, 45:2215-2222.
85. Zicca A., Cafaggi S., Mariggio M.A., Vannozzi M.O., Ottone M., Bocchini V., Caviglioli G., Viale M. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. Eur. J. Pharmacol. 2004, 442:265-272.